Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa. - Wikidata - awgldk - TriplyDB

Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.

Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.

http://www.wikidata.org/entity/Q34749647

about

Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole.Wnt3A Induces GSK-3β Phosphorylation and β-Catenin Accumulation Through RhoA/ROCK.CRM197 in Combination With shRNA Interference of VCAM-1 Displays Enhanced Inhibitory Effects on Human Glioblastoma Cells.Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells.Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells.Riluzole: a potential therapeutic intervention in human brain tumor stem-like cells.

P2860

Q33591900-A186732B-689E-4E56-8AB9-D861AC814C3C Q36288488-17920F6A-6EDF-4B62-BE19-15D2C09E2D62 Q38411147-B5F70AC0-9764-49AB-B8CE-D41D37972AD1 Q38958467-3E73251D-3A56-45F9-B001-01E1F6549B0A Q38970520-EDA6D8FC-104C-42B4-96CB-84046BC8D6A3 Q43640727-512EE396-97F7-4AE5-BCAA-E45EB26EF2FA Q47117433-E0EAB0E7-0921-4AE7-B294-A2B15989EE3C

P2860

Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.

http://www.wikidata.org/entity/Q34749647

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Synergistic inhibition of surv ...... nation of LY341495 and Iressa.

@ast

Synergistic inhibition of surv ...... nation of LY341495 and Iressa.

@en

Synergistic inhibition of surv ...... nation of LY341495 and Iressa.

@nl

type

label

Synergistic inhibition of surv ...... nation of LY341495 and Iressa.

@ast

Synergistic inhibition of surv ...... nation of LY341495 and Iressa.

@en

Synergistic inhibition of surv ...... nation of LY341495 and Iressa.

@nl

prefLabel

Synergistic inhibition of surv ...... nation of LY341495 and Iressa.

@ast

Synergistic inhibition of surv ...... nation of LY341495 and Iressa.

@en

Synergistic inhibition of surv ...... nation of LY341495 and Iressa.

@nl

P1433

Q34749647-507DB549-A199-4809-81A5-BF02D193BF2B

P1476

Q34749647-B019D933-A7BC-4165-83DB-B28E985A1BC1

P2093

Q34749647-1E4D8D51-5338-4D2E-BBD0-FA513157C879

Q34749647-436A321C-F11F-48EB-8E50-3602AA3D2315

Q34749647-44CE3ED7-7409-428E-84D2-15797D73B860

Q34749647-97BEB2D7-7801-46A2-A2CB-F95484CC6093

Q34749647-BE0DC671-281B-4906-8A1B-B173C804F0AF

Q34749647-D68AD2DA-6551-4DE4-A2CF-FAA2750B590F

P2860

Q34749647-04BCF9E1-9CAD-4FEB-8037-384AEBFCDFB1

Q34749647-067AD06E-E7A9-48A8-92D4-A6B6FF33A868

Q34749647-2383D4B5-3E73-4201-801C-7D469653019B

Q34749647-2AEEFA61-6702-4193-9460-4EE9F9D68A0B

Q34749647-2DC0333E-251C-4DEB-A04C-ADCDAD5A339A

Q34749647-2ED21F94-74AB-4091-A5E9-31C4CC361A2A

Q34749647-3A0931ED-3B01-4736-9DCD-780D8BF7D7AD

Q34749647-3D37F48B-F2FD-4928-8B65-674B54CF6CCE

Q34749647-45990830-001D-47FC-A894-A650FAE9844D

Q34749647-4AB357A5-4E3F-4180-A184-A267C3D2991D

P304

Q34749647-0A3ABB0C-82A5-47A7-9235-AFB57C944A4A

P31

Q34749647-CBE6B7B9-8694-4A62-A584-AA1AABE7C765

P356

Q34749647-A8CA8678-CA64-4615-BB7F-D6449AE810AD

P407

Q34749647-917B6675-E117-457D-AE63-A7624841A1A5

P433

Q34749647-F8F320D2-7D25-4D4D-9C49-ECE838230C52

P478

Q34749647-3D3EAFD8-79F7-4932-8A81-CDC9A7FC53F3

P577

Q34749647-094E4941-AB69-4E33-9E25-98E08F562983

P5875

Q34749647-4F91A9AE-F801-41AF-8825-FFC790074DA3

P698

Q34749647-3082467F-09FC-445A-AEDB-94763CCF684D

P932

Q34749647-DBFE9E3A-7400-4EB9-A2BD-EC43F7FAD9DF

P356

JOURNAL.PONE.0064588

P1433

P1476

Synergistic inhibition of surv ...... nation of LY341495 and Iressa.

@en

P2093

Devon Morgan

http://www.w3.org/2001/XMLSchema#string

Ewa Dubisz

http://www.w3.org/2001/XMLSchema#string

Hira Gulzar

http://www.w3.org/2001/XMLSchema#string

Shahana S Mahajan

http://www.w3.org/2001/XMLSchema#string

Vangie Carrillo

http://www.w3.org/2001/XMLSchema#string

Zarina Yelskaya

http://www.w3.org/2001/XMLSchema#string

P2860

Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

The PI3K-PDK1 connection: more than just a road to PKB

Underediting of glutamate receptor GluR-B mRNA in malignant gliomas

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B

Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange

Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site

Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha

Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B

P304

e64588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0064588

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236978618

http://www.w3.org/2001/XMLSchema#string

P698

23724064

http://www.w3.org/2001/XMLSchema#string

P932

3664620

http://www.w3.org/2001/XMLSchema#string